Join
Live feed
·
INSIDERFilingvia Quantisnow
Aptose Biosciences Inc. logo

New insider Hanmi Pharmaceutical Co., Ltd. claimed ownership of 508,710 shares (SEC Form 3)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track APTO (Aptose Biosciences Inc.) and more on Quantisnow.